CARULLI, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.846
EU - Europa 3.773
AS - Asia 1.220
SA - Sud America 22
AF - Africa 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.818
GB - Regno Unito 1.251
IT - Italia 715
CN - Cina 505
SE - Svezia 472
DE - Germania 435
UA - Ucraina 313
HK - Hong Kong 259
TR - Turchia 216
FI - Finlandia 166
FR - Francia 111
BG - Bulgaria 110
SG - Singapore 68
RU - Federazione Russa 53
IN - India 42
BE - Belgio 28
CA - Canada 23
IE - Irlanda 20
ID - Indonesia 18
JP - Giappone 16
NL - Olanda 15
CZ - Repubblica Ceca 14
IR - Iran 14
BD - Bangladesh 13
ES - Italia 13
CH - Svizzera 12
VN - Vietnam 12
MY - Malesia 10
TW - Taiwan 10
CL - Cile 9
KR - Corea 8
NO - Norvegia 8
AU - Australia 7
LT - Lituania 7
IQ - Iraq 6
PL - Polonia 6
BR - Brasile 5
ET - Etiopia 5
EU - Europa 5
MX - Messico 5
PH - Filippine 5
RO - Romania 4
SI - Slovenia 4
UG - Uganda 4
EC - Ecuador 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
PK - Pakistan 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
CO - Colombia 2
DK - Danimarca 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TJ - Tagikistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BY - Bielorussia 1
EG - Egitto 1
KZ - Kazakistan 1
LV - Lettonia 1
PE - Perù 1
RS - Serbia 1
Totale 13.887
Salva come PNG Salva come JPEG
Città #
Fairfield 1.379
Southend 978
Woodbridge 759
Houston 716
Chandler 697
Ashburn 692
Jacksonville 542
Cambridge 463
Seattle 461
Wilmington 423
Dearborn 416
Ann Arbor 408
Nyköping 319
Hong Kong 255
Modena 220
Beijing 164
San Diego 154
Izmir 134
Princeton 121
Sofia 110
Eugene 101
New York 84
Helsinki 78
Fremont 54
Des Moines 46
Shanghai 44
London 41
Singapore 41
Redwood City 38
Boardman 30
Milan 30
Brussels 26
Falls Church 26
Bremen 25
Bologna 24
Hefei 22
San Mateo 22
Rome 19
Jakarta 18
Dongguan 17
Hounslow 17
Norwalk 17
Kunming 16
Kilburn 14
Parma 14
Phoenix 14
Brno 13
Dublin 13
Frankfurt am Main 13
Guangzhou 13
Toronto 13
Grafing 12
Chiswick 11
Nanjing 11
Bari 10
Nanchang 10
Dong Ket 9
Taipei 9
Kocaeli 8
Rio Saliceto 8
Baotou 7
Dhaka 7
Indiana 7
Leawood 7
Ottawa 7
Shenyang 7
Verona 7
Formia 6
Fuzhou 6
Istanbul 6
Los Angeles 6
Prescot 6
Rho 6
Baghdad 5
Catania 5
Dallas 5
Harbin 5
Jinan 5
Madrid 5
Monmouth Junction 5
Mountain View 5
Nishinotoindori 5
Saint Petersburg 5
San Francisco 5
Albignasego 4
Auburn Hills 4
Augusta 4
Belvedere Spinello 4
Berlin 4
Carpi 4
Florence 4
Hebei 4
Kampala 4
Livorno 4
Palermo 4
Reggio Emilia 4
San Giovanni la Punta 4
Sassuolo 4
Southwark 4
Sydney 4
Totale 10.646
Salva come PNG Salva come JPEG
Nome #
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 284
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 268
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 260
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 242
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 220
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 217
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 214
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 210
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 209
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 204
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 202
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 200
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 198
Telomere length elongation after weight loss intervention in obese adults 198
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 190
Gender, fatty liver and GGT 186
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 178
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 177
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 176
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 175
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 174
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 172
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 171
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 170
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 170
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 169
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 168
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 166
Review article: diabetes, genetics and ethnicity 164
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 161
Telomere and telomerase in chronic liver disease and hepatocarcinoma 157
Endocrine and liver interaction: the role of endocrine pathways in NASH 157
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 156
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 154
Review article: effect of bile salt pool composition on hepatic and biliary functions 154
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 152
Hepatic steatosis and insulin resistance: Does etiology make a difference? 147
Telomere shortening as genetic risk factor of liver cirrhosis 147
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 144
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 138
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 137
Reply 135
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 133
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 131
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 129
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 129
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 128
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 128
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 127
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 125
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 125
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 125
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 120
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 119
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 119
Telomeres and atherosclerosis 118
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 116
Olanzapine metabolic side effects: a weight gain issue? 115
Regolazione della sintesi di colesterolo e acidi biliari 113
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 111
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 109
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 109
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 109
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 107
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 107
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 106
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 106
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 104
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 102
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 100
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 99
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 97
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 97
Genetic polymorphisms in subjects with Non Alcoholic Fatty Liver Disease. 95
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 95
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 95
The genetic basis of Insulin resistance. A brief review 94
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 94
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 93
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 93
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 91
Cirrosi criptogenetiche. Un report di 5 pazienti 84
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 83
Risk for cardiovascular events in a local population of diabetic patients 81
non alcoholic fatty liver disease ( NAFLD) :is femlae sex safer? 80
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 80
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 79
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 78
Invecchiamento ed alterazioni dell’omeostasi del colesterolo: studi dei livelli plasmatici degli steroli idrossilati come markers metabolici. 77
La calcolosi biliare. 76
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 75
Epatopatia steatosica non alcolica:definizione e aspetti clinici. 74
Sindromi steatosiche non alcoliche. Stato dell'arte e progressi nella ricerca. 73
Fatty liver, carotid disease and gallstones: A study ofage-related associations 72
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 72
Cholestatic icterus: is there still a role for the clinic? 72
Does fatty liver associate with carotid atherosclerosis? 70
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 70
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 69
determinants of lt levels and fibrosis in non alcoholic fatty liver disease 67
Totale 13.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019479 0 0 0 0 0 0 0 0 0 0 0 479
2019/20203.012 191 186 108 188 319 470 552 323 278 124 173 100
2020/20212.596 244 88 201 369 360 142 229 268 123 290 183 99
2021/20222.398 108 303 160 203 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.331 55 71 86 91 253 134 209 165 26 31 65 145
Totale 14.068